Study objective
To determine if day 3 FSH and E2 levels at the upper limits of normal affect live birth rates and treatment trajectory in a conventional vs. ‘fast track’ treatment program for IVF.
Design
Secondary analysis of two randomized controlled trials, FASTT and FORT-T.
Setting
Multicenter study in a state with mandated insurance coverage.
Patients
Infertile women ages 21 to 42 years randomized to conventional or accelerated treatment with controlled ovarian hyperstimulation (COH)-IUI and/or IVF (n=603 patients contributing 2,717 total cycles).
Interventions
Patients were stratified according to basal FSH and E2: FSH <10mIU/mL and E2 <40pg/mL (Group 1A), FSH <10mIU/mL and E2 ≥40 pg/mL (Group 1B), FSH 10–15 mIU/mL and E2 <40pg/mL (Group 2A) and FSH 10–15 mIU/mL and E2 ≥40 pg/mL (Group 2B).
Main outcome measures
Number of cancelled cycles, disenrollment for poor response and cumulative live birth rates per couple.
Results
Women in Groups 2A and 2B were more likely to have cancelled cycles and be disenrolled for poor response. While no live births occurred in Group 2B during COH-IUI (0/19 couples, 0/58 cycles), IVF still afforded these patients a reasonable chance of success (6/18 couples, 6/40 cycles, 33.3% live birth rate per couple). The specificity and positive predictive value of basal FSH 10–15 mIU/mL and E2 ≥40 pg/mL for no live birth during COH-IUI treatment were both 100%.
Conclusions
Women who initiated infertility treatment with FSH 10–15 mIU/mL and E2 ≥ 40 pg/mL on day 3 testing were unlikely to achieve live birth after COH-IUI treatment.